Newsroom
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
Media Center
Media
Venture Investment in Crispr Gene Editing Spurs Innovation, Hunt for IP
March 11, 2022
Wall Street Journal
Read Now
Press Release
Venture Investment in Crispr Gene Editing Spurs Innovation, Hunt for IP
March 11, 2022
Wall Street Journal
Read Now
Media
Appointments and advancements
March 10, 2022
BioWorld
Read Now
Press Release
Appointments and advancements
March 10, 2022
BioWorld
Read Now
Media
Management Tracks
March 10, 2022
BioCentury
Read Now
Press Release
Management Tracks
March 10, 2022
BioCentury
Read Now
Press Release
Scribe Therapeutics Appoints David Parrot as Chief Financial Officer and George Manning as Controller
March 9, 2022
Read Now
Press Release
Scribe Therapeutics Appoints David Parrot as Chief Financial Officer and George Manning as Controller
March 9, 2022
Read Now
Media
Big Pharma is waking up to the booming field of gene editing. Here are the top 18 biotechs to know in 2022 that are poised to grab the drug industry's attention.
January 31, 2022
Business Insider
Read Now
Press Release
Big Pharma is waking up to the booming field of gene editing. Here are the top 18 biotechs to know in 2022 that are poised to grab the drug industry's attention.
January 31, 2022
Business Insider
Read Now